GlassScriptPhysician profile
Thomas Payne Royals
NPI 1184068413
$9,799.45
in general payments reported to CMS, 2019-2025
23 companies · $626 in 2025
The $626 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,399 · 2020: $1,176 · 2021: $90.75 · 2022: $2,052 · 2023: $1,266 · 2024: $190 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Travel and Lodging: $657 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.02 |
| Travel and Lodging | $657.24 |
| Education | $278.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alon Medical Technology | $2,765.89 | 2019-2025 | |
| Arthrex, INC. | $2,682.46 | 2019-2023 | Distal Extremities Implants Soft Tissue H&W Mini Tightropes, Arthroplasty Implants Revers Total Shoulder Modular Glenoid Systems |
| Axogen | $1,871.75 | 2019 | |
| Zimmer Biomet Holdings, INC. | $1,252.28 | 2023-2025 | Comprehensive Shoulder System, Osseofit, Juggerknotless Soft Anchor |
| Ensemble Orthopedics, INC | $226.28 | 2022-2023 | Ensemble Cmc |
| Smith+Nephew, INC. | $156.79 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Endo Pharmaceuticals INC. | $144.55 | 2019 | |
| Stryker Corporation | $129.41 | 2024-2025 | Inspace, Axsos, Aequalis Perform Reversed |
| Depuy Synthes Sales INC. | $80.06 | 2022 | |
| Ferring Pharmaceuticals INC. | $68.88 | 2019-2021 | |
| Medartis INC. | $58.00 | 2021 | |
| Integra Lifesciences Corporation | $50.79 | 2020 | |
| Kerecis Limited | $46.12 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Fx Shoulder Solutions, INC | $41.43 | 2019 | |
| Endo USA, INC. | $38.71 | 2025 | Xiaflex |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $33.61 | 2024 | Puraply Am |
| Skeletal Dynamics INC | $33.22 | 2025 | Ijs, Implate, Align |
| Linvatec Corporation | $32.92 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $18.97 | 2025 | |
| Medela LLC | $17.71 | 2024 | Invia Motion Endure |
| Pacira Therapeutics, INC. | $17.07 | 2021 | |
| Fidia Pharma USA INC. | $16.55 | 2019-2020 | |
| Sonex Health, INC. | $16.00 | 2024 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Royals listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.